Back to search
FDAFDA · Food and drugs·Recall number D-1189-2018

Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.

Published September 19, 2018 · Recall initiated: August 27, 2018

Summary

FDA records drug Class I recall D-1189-2018, published September 19, 2018 and initiated August 27, 2018. Recalling firm: SCA Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 1384 bags; Lot: Lots: 20180711@18, BUD: 10/3/2018; 20180712@19, 20180712@21, 20180712@24 BUD: 10/4/2018; 20180713@19, BUD: 10/5/2018; 20180727@21, BUD: 10/19/2018; 20180803@20, BUD: 10/26/2018. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals, Inc.
Distributor
Three hospitals in DC, VA, CT
Lot
Lots: 20180711@18, BUD: 10/3/2018; 20180712@19, 20180712@21, 20180712@24 BUD: 10/4/2018; 20180713@19, BUD: 10/5/2018; 20180727@21, BUD: 10/19/2018; 20180803@20, BUD: 10/26/2018
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032. recalled?

Yes. FDA published recall D-1189-2018 on September 19, 2018. Reported hazard: Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.

What should I do if I have this product?

Voluntary: Firm initiated · Letter